Vaccines for preventing herpes zoster (shingles) in older adults

May 5, 2016

Source: Cochrane 

Follow this link for abstract

Date of publication: March 2016

Publication Type: Cochrane Review

In a nutshell: Herpes zoster vaccine is effective in preventing herpes zoster disease and this protection can last three years. In general, zoster vaccine is well tolerated; it produces few systemic adverse events and injection site adverse events of mild to moderate intensity.


The introduction of a new preventive vaccine for shingles

November 25, 2013

Source: Practice Nursing, 24 (11), 01 Nov 2013, pp 550 – 555

Follow this link for abstract

Date of publication: November 2013

Publication Type: Journal Article

In a nutshell: Simon Oakley and Adam Goodband look at the treatment and management of shingles and consider the efficacy of a preventive vaccine.

Length of publication: 4-page article


Shingles vaccine stocks may run out, officials warn

October 28, 2013

Source: GP Online

Follow this link for full-text

Date of publication: October 2013

Publication Type: News

In a nutshell: Disruption to the shingles vaccination campaign is expected to continue into next month as delays to supplies threaten to exhaust UK stocks of the vaccine.

Length of publication: 1-page news story


GPs told to refuse shingles vaccination for 71 to 78 year olds

October 28, 2013

Source: Pulse

Follow this link for full-text

Date of publication: October 2013

Publication Type: News

In a nutshell: GPs are being told to turn down requests from people aged 71 to 78 years for the shingles vaccination even though this goes against patients’ rights under the NHS constitution. Pulse has learned that in many areas patients over 70 but under 79 years have been asking for the vaccination after hearing reports about the national programme, with GPs having to explain why they are not yet covered. Public Health England (PHE) said everyone aged 70 to 79 years is entitled to the vaccination under the NHS Constitution, as recommended by the Joint Committee on Vaccinations and Immunisations (JCVI). However, to make the best use of limited vaccine supplies, the programme is being rolled out to patients aged 70 and those aged 79 years to begin with.

Length of publication: 1-page news story


Shingles jab campaign for people in their 70s

September 2, 2013

Source: BBC News

Follow this link for full-text

Date of publication: September 2013

Publication Type: News

In a nutshell: People in their 70s across the UK will be offered a vaccine against shingles from this week. The government-led programme will initially offer the vaccine to those aged 70, 78 and 79.

Length of publication: 1-page news item


Shingles vaccine to be routine for people in their 70s

May 23, 2013

Source: BBC News

Follow this link for full-text

Date of publication: April 2013

Publication Type: News

In a nutshell: People in their 70s across the UK will be offered a vaccine against shingles from this September. Experts have been recommending routine immunisation against the disease, which causes a painful rash, for some years. The government-led programme will target 70, 78 and 79-year-olds in the first instance and should prevent tens of thousands of cases a year. Elderly people are at greatest risk and vaccination should prevent nearly half of cases in the over-70s.

Length of publication: 1-page news item


Herpes Zoster Vaccine Effectiveness against Incident Herpes Zoster and Post-herpetic Neuralgia in an Older US Population: A Cohort Study

April 19, 2013

Source: PLOS Medicine, April 2013, 10(4), e1001420

Follow this link for abstract

Date of publication: April 2013

Publication Type: Article

In a nutshell: These findings show that shingles vaccine uptake is low among elderly people in the US and varies between different patient groups. They show that shingles vaccination is effective against incident shingles in a general population of older individuals, including those who are immunosuppressed, and suggest that shingles vaccination is effective against post-herpetic neuralgia… these findings provide useful information for policy makers in countries that are currently considering the introduction of shingles vaccination into routine practice. Moreover, they highlight the need to increase shingles vaccination among elderly individuals in the US, the section of the population at the highest risk of post-herpetic neuralgia.

Length of publication: 11-page article

Related Stories: 

Vaccine against herpes zoster halves incidence in older people, finds study, BMJ 2013; 346:f2349

 Zoster vaccine protects against shingles, BMJ 2013; 346:f2389